The global in-vitro diagnostics market size is expected to account for USD 180.62 Billion in 2032 and register a robust revenue CAGR of 4.6% during the forecast period. Key factors driving market revenue growth are increasing prevalence of chronic diseases and rising demand for Point-of-Care (PoC) molecular diagnostics. Increasing adoption of rapid diagnostic kits is another factor expected to...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek